| dc.contributor.author | Winarso, Hudi | |
| dc.date.accessioned | 2020-04-20T08:59:45Z | |
| dc.date.available | 2020-04-20T08:59:45Z | |
| dc.date.issued | 2018-04 | |
| dc.identifier.uri | http://dspace.uc.ac.id/handle/123456789/2554 | |
| dc.description.abstract | Male hypogonadism is a condition in which the body doesn’t produce enough testosterone- the hormone that plays a key role in masculine growth and development during puberty – or has an impaired ability to produce sperm or both.
There are two basic types of hypogonadism :
- Primary. The type of hypogonadism – also known as primary testicular failure – originates from a problem in the testicles.
- Secondary. This type of hypogonadism indicates a problem in the hypothalamus or the pituitary gland – parts of the brain that signal the testicles to produce testosterone.
Primary hypogonadism is associated with low levels of testosterone and high-normal to high levels of LH and FSH. For the diagnosis of primary hypogonadism, FSH measurement is partially important because FSH has a longer half life, is more sensitive, and demonstrates less variability than LH
In case of primary hypogonadism in pre pubertal male, life-long testosterone treatment is needed. Treatment is initiation of therapy with small doses of testosterone (50 – 100 mg IM) every 3 or 4 weeks at the appropriate psychosocial stage in development. When a final adult height is thought to have been obtained, the adult dose of testosterone replacement is inaugurated. | en_US |
| dc.language.iso | other | en_US |
| dc.publisher | PERSANDI (Perhimpunan Dokter Spesialis Andrologi Indonesia) | en_US |
| dc.subject | Hypogonadism, genetic, hormonal | en_US |
| dc.title | Evaluation for Primary Hypogonadism | en_US |
| dc.type | Other | en_US |